Stoke Therapeutics's total assets for Q3 2024 were $293.32M, a decrease of -4.69% from the previous quarter. STOK total liabilities were $61.21M for the fiscal quarter, a -5.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.